Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome

NCT01174459 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT01174459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01174459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
August 31, 2010
Completion date
August 31, 2013
Enrollment
571 (actual)
Sites
159

Conditions

As the registry lists them; a condition with its own page is linked.

restless legs syndrome